Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 240.193 million compared to CNY 404.424 million a year ago. Operating loss was CNY 53.040 million compared to operating Income of CNY 30.740 million a year ago. Net loss was CNY 28.056 million compared to net income of CNY 39.156 million a year ago. Basic loss per share from continuing operations was CNY 0.09 compared to basic earnings per share from continuing operations of CNY 0.12 a year ago.